MedPath

Clinical observation of Dan-Hong Hua-Yu oral solution in treating retinal vein occlusio

Not Applicable
Conditions
Retinal vein occlusion
Registration Number
ITMCTR2000003100
Lead Sponsor
Beijing Hospital of traditional Chinese Medicine Affiliated to Capital Medical University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Those who meet the diagnosis of traditional Chinese and western medicine RVO and have no other fundus lesions;
2. Aged between 30-65 years;
3. Patients who are within 1 month of onset and can persist in treatment for 3 months;
4. After obtaining the consent of patients and their families, the patients who voluntarily join the study;

Exclusion Criteria

1. Patients with other ophthalmopathy affecting the evaluation of curative effect;
2. Women during pregnancy or lactation;
3. Patients who have taken hormonal drugs in the past 3 months or have been treated with this research protocol.
4. People with severe heart, liver, and kidney dysfunction and mental disorders;
5. Subjects participating in other clinical studies.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Slit lamp inspection and intraocular pressure measurement;Vision (including naked and corrected vision);
Secondary Outcome Measures
NameTimeMethod
Traditional Chinese medicine syndrome score;
© Copyright 2025. All Rights Reserved by MedPath